Examining Weight Suppression, Leptin Levels, Glucagon-Like Peptide 1 Response, and Reward-Related Constructs in Severity and Maintenance of Bulimic Syndromes: Protocol and Sample Characteristics for a Cross-Sectional and Longitudinal Study
JMIR Research Protocols · 2025
DOI: 10.2196/66554 ↗At a glance
Querschnittstudie in JMIR Research Protocols, 2025. Written by Pamela K Keel and 9 co-authors. Institution: Department of Psychology, Florida State University, Tallahassee, FL, United States. Major MEDLINE topics: Reward, Leptin, Glucagon-Like Peptide 1, Bulimia. Cited 5 times so far (Crossref); 134 references. The full text is freely available in PubMed Central. Funded by: NIMH NIH HHS.
Abstract (original language)
Background
Bulimia nervosa and related syndromes (BN-S) characterized by binge eating vary considerably in illness severity and course. Using the Research Domain Criteria framework of the National Institute of Mental Health, we developed a model positing that the same set of physiological consequences of weight suppression (WS; defined as the difference between the highest and current adult body weight) contribute to binge-eating severity and maintenance by (1) increasing the drive or motivation to consume food (reward valuation effort [RVE]) and (2) decreasing the ability for food consumption to lead to a state of satiation or satisfaction (reward satiation).
Objective
Our funded project aimed to test concurrent associations among WS, physiological factors (leptin concentrations and postprandial glucagon-like peptide 1 [GLP-1] response), behavioral indicators of RVE (breakpoint on progressive ratio tasks) and reward satiation (ad-lib test meal intake), self-report of these core constructs, and binge-eating severity in BN-S (aim 1); test prospective associations to determine whether WS predicts BN-S maintenance in longitudinal models and whether posited mediators also predict BN-S maintenance (aim 2); and determine whether associations between WS and BN-S severity and maintenance are mediated by alterations in leptin levels, GLP-1 response, RVE, and reward satiation (aim 3).
Methods
We aimed to recruit a sample of 320 women with BN-S or noneating disorder controls, with BMI from 16 kg/m2 to 35 kg/m2, for our study. The study included diagnostic interviews; questionnaires; height, weight, and percentage of body fat measurements; weight history; fasting leptin level; postprandial GLP-1 and insulin responses to a fixed meal; and ad-lib meal and progressive ratio tasks to behaviorally measure reward satiation and RVE, respectively, at baseline, with at least 78.1% (250/320) of the participants providing data at 6- and 12-month follow-up visits. Data will be analyzed using structural equation models to test posited pathways.
Results
Data collection began in November 2016 and ended in April 2023, pausing in-person data collection from March 2020 to February 2021 due to the COVID-19 pandemic. Of 399 eligible women enrolled, 290 (72.7%) provided clinical, behavioral, and biological data at baseline, and 249 (62.4%) provided follow-up data. Measures demonstrated strong psychometric properties.
Conclusions
We seek to identify biobehavioral predictors to inform treatments that target key factors influencing the severity and course of binge eating. These data, supported solely through federal funding, can inform questions emerging from recent interest and controversy surrounding the use of GLP-1 agonists for binge eating. International Registered Report Identifier (IRRID) RR1-10.2196/66554
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Psychology, Florida State University, Tallahassee, FL, United States.
- Department of Psychology, Western University, London, ON, Canada.
- Department of Psychology, Louisiana State University, Baton Rouge, LA, United States.
- College of Medicine, University of Central Florida, Orlando, FL, United States.
- Precisionary Instruments, Ashland, MA, United States.
- Department of Psychology, Ohio University, Athens, OH, United States.
ORCID profiles: Pamela K Keel, Lindsay P Bodell, Sarrah I Ali, Austin Starkey, Jenna Trotta, J Woody Luxama, Chloé Halfhide, Naomi G Hill, Jonathan Appelbaum, Diana L Williams
Funding
- NIMH NIH HHS
Cite
APA
Keel, P. K., Bodell, L. P., Ali, S. I., Starkey, A., Trotta, J., Luxama, J. W., Halfhide, C., Hill, N. G., Appelbaum, J., & Williams, D. L. (2025). Examining Weight Suppression, Leptin Levels, Glucagon-Like Peptide 1 Response, and Reward-Related Constructs in Severity and Maintenance of Bulimic Syndromes: Protocol and Sample Characteristics for a Cross-Sectional and Longitudinal Study. JMIR Research Protocols. https://doi.org/10.2196/66554
Vancouver
Keel PK, Bodell LP, Ali SI, Starkey A, Trotta J, Luxama JW, et al. Examining Weight Suppression, Leptin Levels, Glucagon-Like Peptide 1 Response, and Reward-Related Constructs in Severity and Maintenance of Bulimic Syndromes: Protocol and Sample Characteristics for a Cross-Sectional and Longitudinal Study. JMIR Research Protocols. 2025. doi:10.2196/66554
BibTeX
@article{Keel2025,
author = {Keel, Pamela K and Bodell, Lindsay P and Ali, Sarrah I and Starkey, Austin and Trotta, Jenna and Luxama, J Woody and Halfhide, Chloé and Hill, Naomi G and Appelbaum, Jonathan and Williams, Diana L},
title = {Examining Weight Suppression, Leptin Levels, Glucagon-Like Peptide 1 Response, and Reward-Related Constructs in Severity and Maintenance of Bulimic Syndromes: Protocol and Sample Characteristics for a Cross-Sectional and Longitudinal Study},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/66554}
}
EUVIMED